Sort   by:  
 Page size 
UnknownBone Deleterious Effects of Different NRTIs in Treatment-naive HIV Patients After 12 and 48 Weeks of Treatment.
Not available
S-EPMC9175084 | biostudies-literature
UnknownGenetic variation in CCR2 and CXCL12 genes impacts on CD4 restoration in patients initiating cART with advanced immunesupression.
Not available
S-EPMC6438540 | biostudies-literature
UnknownPresence of rare potential pathogenic variants in subjects under 65 years old with very severe or fatal COVID-19.
Not available
S-EPMC9208539 | biostudies-literature
UnknownExpanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events.
Not available
S-EPMC10474064 | biostudies-literature
UnknownDiscovering HIV related information by means of association rules and machine learning.
Not available
S-EPMC9616424 | biostudies-literature
UnknownLong-term effectiveness and tolerability of dolutegravir/lamivudine in treatment-naive people with HIV: an analysis of a multicentre cohort at 96 weeks.
Not available
S-EPMC11879157 | biostudies-literature
UnknownChanges in Body Mass Index in Children and Adolescents Living With Human Immunodeficiency Virus in Europe and Thailand Starting Dolutegravir.
Not available
S-EPMC12712701 | biostudies-literature
UnknownEffectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice.
Not available
S-EPMC10232237 | biostudies-literature
UnknownShould we measure quality of life among people with HIV? A multicentre survey of physicians' opinions in Spain.
Not available
S-EPMC11786618 | biostudies-literature
UnknownReal-world Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Comparison With Other Regimens in People With HIV Starting Therapy With AIDS-Defining Conditions: Results From the CoRIS Cohort-The ACTUAS II Study.
Not available
S-EPMC12596416 | biostudies-literature
Sort   by:  
 Page size